Skip to main content
Caplight Logo









N-Power Medicine

N-Power Medicine

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.npowermedicine.com/

Last Round

Series B

Sep 1, 2026

Total Funding Raised

$117M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

N-Power Medicine is a biotechnology company that provides an AI-enabled clinical research platform to accelerate oncology drug development by integrating research workflows into community oncology practices.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Precision Medicine, Healthcare Analytics, Data Integration

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

external control armProECAclinical trial accelerationreal-world dataRWDprecision medicineclinical data integrationoncology researchpoint-of-care platformclinical trial softwaresynthetic control armchart review automationhuman-in-the-loopdata as a serviceDaaSclinical workflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

N-Power Medicine Comparables

Compare N-Power Medicine with similar companies based on industry and business-model similarity.

N-Power Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pi Health
81%
xCures
81%
Verana Health
80%

N-Power Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 1, 2026
StrategicDec 30, 2024
Series BJul 1, 2024

Key People

Founding team and executive leadership

Soo Bang

Corporate Business Development & Strategic Advisor to CEO

Executive Team

Joel Smith

Chief Financial Officer

Executive Team

N-Power Medicine Investors

Notable investors and investment history

N-Power Medicine investors
InvestorRounds
Innovatus Capital PartnersStrategic, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    $32M round with Merck & Co., Inc. and Innovatus Capital Partners.

  • Jul 26, 2026

    Monthly visitors increased 87% MoM.

N-Power Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

N-Power Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about N-Power Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range102
Year Founded2021
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?